Overview

Sibutramine to Reduce Weight Gain and Improve Smoking Cessation Rates

Status:
Completed
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if sibutramine will decrease post-cessation weight gain and cigarette smoking in overweight and obese smokers who quit smoking.
Phase:
N/A
Details
Lead Sponsor:
University of Tennessee
Collaborator:
National Heart, Lung, and Blood Institute (NHLBI)
Treatments:
Sibutramine